Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yi Gan Ming Mu oral liquid for chronic hepatitis B-related liver injury
ChiCTR-IPC-15006627Phase 4Not yet recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jun 2015
- Countries
- 1
01
Overview
Phase 4, open-label trial of yi gan ming mu in Chronic Hepatitis B (CHB) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoints: total bilirubin, direct bilirubin and 5 more. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
yi gan ming mu
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-IPC-15006627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPC-15006627.